Investors and Media
Press Releases
June 23, 2025
Scholar Rock to Present Comprehensive Update at 2025 Annual Cure SMA Research and Clinical Care Meeting, Including Positive Results from Pivotal Phase 3 SAPPHIRE Trial
June 18, 2025
Scholar Rock Reports Positive Phase 2 EMBRAZE Trial Results Demonstrating Statistically Significant Preservation of Lean Mass with Apitegromab During Tirzepatide-Induced Weight Loss
June 13, 2025
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 5, 2025
Scholar Rock to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference
June 2, 2025
Scholar Rock Appoints Rebecca McLeod Chief Brand Officer and U.S. General Manager
May 28, 2025
Scholar Rock to Present at the Jefferies Global Healthcare Conference
May 16, 2025
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 14, 2025
